323 related articles for article (PubMed ID: 28424286)
1. Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression.
Kiguoya MW; Mann JK; Chopera D; Gounder K; Lee GQ; Hunt PW; Martin JN; Ball TB; Kimani J; Brumme ZL; Brockman MA; Ndung'u T
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424286
[TBL] [Abstract][Full Text] [Related]
2. Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa.
Farinre O; Gounder K; Reddy T; Tongo M; Hare J; Chaplin B; Gilmour J; Kanki P; Mann JK; Ndung'u T
Retrovirology; 2021 May; 18(1):11. PubMed ID: 33952315
[TBL] [Abstract][Full Text] [Related]
3. Mother-to-Child HIV Transmission Bottleneck Selects for Consensus Virus with Lower Gag-Protease-Driven Replication Capacity.
Naidoo VL; Mann JK; Noble C; Adland E; Carlson JM; Thomas J; Brumme CJ; Thobakgale-Tshabalala CF; Brumme ZL; Brockman MA; Goulder PJR; Ndung'u T
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637761
[TBL] [Abstract][Full Text] [Related]
4. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
5. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
6. Gag-protease-mediated replication capacity in HIV-1 subtype C chronic infection: associations with HLA type and clinical parameters.
Wright JK; Brumme ZL; Carlson JM; Heckerman D; Kadie CM; Brumme CJ; Wang B; Losina E; Miura T; Chonco F; van der Stok M; Mncube Z; Bishop K; Goulder PJ; Walker BD; Brockman MA; Ndung'u T
J Virol; 2010 Oct; 84(20):10820-31. PubMed ID: 20702636
[TBL] [Abstract][Full Text] [Related]
7. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin.
Gao F; Robertson DL; Morrison SG; Hui H; Craig S; Decker J; Fultz PN; Girard M; Shaw GM; Hahn BH; Sharp PM
J Virol; 1996 Oct; 70(10):7013-29. PubMed ID: 8794346
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness.
van Domselaar R; Njenda DT; Rao R; Sönnerborg A; Singh K; Neogi U
J Virol; 2019 May; 93(9):. PubMed ID: 30760577
[TBL] [Abstract][Full Text] [Related]
9. Influence of Gag-protease-mediated replication capacity on disease progression in individuals recently infected with HIV-1 subtype C.
Wright JK; Novitsky V; Brockman MA; Brumme ZL; Brumme CJ; Carlson JM; Heckerman D; Wang B; Losina E; Leshwedi M; van der Stok M; Maphumulo L; Mkhwanazi N; Chonco F; Goulder PJ; Essex M; Walker BD; Ndung'u T
J Virol; 2011 Apr; 85(8):3996-4006. PubMed ID: 21289112
[TBL] [Abstract][Full Text] [Related]
10. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.
Aralaguppe SG; Winner D; Singh K; Sarafianos SG; Quiñones-Mateu ME; Sönnerborg A; Neogi U
J Med Virol; 2017 Jan; 89(1):106-111. PubMed ID: 27328744
[TBL] [Abstract][Full Text] [Related]
11. Impact of HLA-B*81-associated mutations in HIV-1 Gag on viral replication capacity.
Wright JK; Naidoo VL; Brumme ZL; Prince JL; Claiborne DT; Goulder PJ; Brockman MA; Hunter E; Ndung'u T
J Virol; 2012 Mar; 86(6):3193-9. PubMed ID: 22238317
[TBL] [Abstract][Full Text] [Related]
12. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
13. The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.
Sharma S; Aralaguppe SG; Abrahams MR; Williamson C; Gray C; Balakrishnan P; Saravanan S; Murugavel KG; Solomon S; Ranga U
BMC Infect Dis; 2017 Jan; 17(1):95. PubMed ID: 28118816
[TBL] [Abstract][Full Text] [Related]
14. A restriction enzyme based cloning method to assess the in vitro replication capacity of HIV-1 subtype C Gag-MJ4 chimeric viruses.
Claiborne DT; Prince JL; Hunter E
J Vis Exp; 2014 Aug; (90):. PubMed ID: 25225725
[TBL] [Abstract][Full Text] [Related]
15. Significant reductions in Gag-protease-mediated HIV-1 replication capacity during the course of the epidemic in Japan.
Nomura S; Hosoya N; Brumme ZL; Brockman MA; Kikuchi T; Koga M; Nakamura H; Koibuchi T; Fujii T; Carlson JM; Heckerman D; Kawana-Tachikawa A; Iwamoto A; Miura T
J Virol; 2013 Feb; 87(3):1465-76. PubMed ID: 23152532
[TBL] [Abstract][Full Text] [Related]
16. Subtype-associated differences in HIV-1 reverse transcription affect the viral replication.
Iordanskiy S; Waltke M; Feng Y; Wood C
Retrovirology; 2010 Oct; 7():85. PubMed ID: 20939905
[TBL] [Abstract][Full Text] [Related]
17. Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression.
Huang SW; Wang SF; Lin YT; Yen CH; Lee CH; Wong WW; Tsai HC; Yang CJ; Hu BS; Lin YH; Wang CT; Wang JJ; Hu Z; Kuritzkes DR; Chen YH; Chen YM
PLoS One; 2014; 9(12):e114441. PubMed ID: 25502811
[TBL] [Abstract][Full Text] [Related]
18. Wide variation in susceptibility of transmitted/founder HIV-1 subtype C Isolates to protease inhibitors and association with in vitro replication efficiency.
Sutherland KA; Collier DA; Claiborne DT; Prince JL; Deymier MJ; Goldstein RA; Hunter E; Gupta RK
Sci Rep; 2016 Nov; 6():38153. PubMed ID: 27901085
[TBL] [Abstract][Full Text] [Related]
19. Emergence of new forms of human immunodeficiency virus type 1 intersubtype recombinants in central Myanmar.
Motomura K; Kusagawa S; Kato K; Nohtomi K; Lwin HH; Tun KM; Thwe M; Oo KY; Lwin S; Kyaw O; Zaw M; Nagai Y; Takebe Y
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1831-43. PubMed ID: 11118069
[TBL] [Abstract][Full Text] [Related]
20. Complex Subtype Diversity of HIV-1 Among Drug Users in Major Kenyan Cities.
Gounder K; Oyaro M; Padayachi N; Zulu TM; de Oliveira T; Wylie J; Ndung'u T
AIDS Res Hum Retroviruses; 2017 May; 33(5):500-510. PubMed ID: 28068781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
